NASDAQ: REVBRevelation Biosciences Inc Stock Ownership - Who owns Revelation Biosciences?
Insider buying vs selling
Have Revelation Biosciences Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Jennifer Carver | Director | 2025-02-11 | 181 | $3.87 | $700.47Buy |
| Lakhmir S. Chawla | Director | 2025-02-11 | 181 | $3.87 | $700.47Buy |
| James Rolke | Chief Executive Officer | 2025-02-11 | 30,095 | $3.87 | $116.47kBuy |
| Jess Roper | Director | 2025-02-11 | 181 | $3.87 | $700.47Buy |
| George F. Tidmarsh | Director | 2025-02-11 | 181 | $3.87 | $700.47Buy |
| Chester Stanley Zygmont Iii | Chief Financial Officer | 2025-02-11 | 15,048 | $3.87 | $58.24kBuy |
REVB insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when REVB insiders and whales buy or sell their stock.
REVB Shareholders
What type of owners hold Revelation Biosciences Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Axa IM Prime Impact Master Fund I Sca Sicavraif | 203.26% | 1,958,984 | $1.58M | Insider |
| Sean H. Fitzpatrick | 183.60% | 1,769,538 | $1.42M | Insider |
| Andreas Typaldos | 183.60% | 1,769,538 | $1.42M | Insider |
| George F. Tidmarsh | 158.06% | 1,523,422 | $1.23M | Insider |
| Lawrence Feis | 77.45% | 746,491 | $600.93k | Insider |
| Glazer Capital LLC | 39.54% | 381,106 | $306.79k | Insider |
| William Howard Carson | 1.04% | 10,000 | $8.05k | Insider |
| David Dobkin | 1.04% | 10,000 | $8.05k | Insider |
| Barry Dennis | 1.04% | 10,000 | $8.05k | Insider |
| Robert D. Nicholson | 1.04% | 10,000 | $8.05k | Insider |
REVB vs Biotech Stocks
Revelation Biosciences Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.